Market Research Logo

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Immunomic Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Immunomic Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Immunomic Therapeutics, Inc.
The report provides overview of Immunomic Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Immunomic Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Immunomic Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Immunomic Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Immunomic Therapeutics, Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Immunomic Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Immunomic Therapeutics, Inc. Snapshot
Immunomic Therapeutics, Inc. Overview
Key Information
Key Facts
Immunomic Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Immunomic Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Immunomic Therapeutics, Inc. - Pipeline Products Glance
Immunomic Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Immunomic Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Immunomic Therapeutics, Inc. - Drug Profiles
TriMix-DC
Product Description
Mechanism of Action
R&D Progress
anti-IL-2R Monoclonal Antibody + LAMP-pp65 Dendritic Cell Vaccine
Product Description
Mechanism of Action
R&D Progress
ASP-4070
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy for HIV
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target EGFRvIII for Glioblastoma Multiforme
Product Description
Mechanism of Action
R&D Progress
MC-LAMP-Vax
Product Description
Mechanism of Action
R&D Progress
pp65 DC + Td
Product Description
Mechanism of Action
R&D Progress
ARA-LAMP-Vax
Product Description
Mechanism of Action
R&D Progress
HIV-LAMP-Vax
Product Description
Mechanism of Action
R&D Progress
TN-LAMP-vax
Product Description
Mechanism of Action
R&D Progress
Antigen mRNA Vaccine + LAMP
Product Description
Mechanism of Action
R&D Progress
JCC-LAMP-Vax
Product Description
Mechanism of Action
R&D Progress
Multi-LAMP-Vax
Product Description
Mechanism of Action
R&D Progress
Immunomic Therapeutics, Inc. - Pipeline Analysis
Immunomic Therapeutics, Inc. - Pipeline Products by Target
Immunomic Therapeutics, Inc. - Pipeline Products by Route of Administration
Immunomic Therapeutics, Inc. - Pipeline Products by Molecule Type
Immunomic Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Immunomic Therapeutics, Inc. - Recent Pipeline Updates
Immunomic Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Immunomic Therapeutics, Inc., Key Information
Immunomic Therapeutics, Inc., Key Facts
Immunomic Therapeutics, Inc. - Pipeline by Indication, 2016
Immunomic Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Immunomic Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Immunomic Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016
Immunomic Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2016
Immunomic Therapeutics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Immunomic Therapeutics, Inc. - Phase II, 2016
Immunomic Therapeutics, Inc. - Phase I, 2016
Immunomic Therapeutics, Inc. - Preclinical, 2016
Immunomic Therapeutics, Inc. - Discovery, 2016
Immunomic Therapeutics, Inc. - Pipeline by Target, 2016
Immunomic Therapeutics, Inc. - Pipeline by Route of Administration, 2016
Immunomic Therapeutics, Inc. - Pipeline by Molecule Type, 2016
Immunomic Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016
Immunomic Therapeutics, Inc. - Recent Pipeline Updates, 2016
Immunomic Therapeutics, Inc., Other Locations
List of Figures
Immunomic Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016
Immunomic Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Immunomic Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Immunomic Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016
Immunomic Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2016
Immunomic Therapeutics, Inc. - Pipeline by Top 10 Target, 2016
Immunomic Therapeutics, Inc. - Pipeline by Route of Administration, 2016
Immunomic Therapeutics, Inc. - Pipeline by Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report